MPG.eBooks - Search Results

121

CADTH Canadian Drug Expert Committee recommendation: Apomorphine hydrochloride (Movapo -- Paladin Labs Inc.) : indication : Parkinson's disease

Published 2018

CADTH

“...The CADTH Canadian Drug Expert Committee (CDEC) recommends that apomorphine hydrochloride...”

Read Now

122

CADTH Canadian Drug Expert Committee recommendation: Sodium zirconium cyclosilicate (Lokelma -- Astrazeneca Canada Inc.) : indication: hyperkalemia

Published 2020

CADTH

“...The CADTH Canadian Drug Expert Committee (CDEC) recommends that sodium zirconium cyclosilicate...”

Read Now

123

CADTH Canadian drug expert committee recommendation: Erenumab (Aimovig -- Novartis pharmaceuticals Canada Inc.) : indication: prevention of migraine

Published 2020

Canadian Agency for Drugs and Technologies in Health

Read Now

124

CADTH Canadian Drug Expert Committee recommendation: Ixekizumab (Taltz -- Eli Lilly Canada Inc.) : indication: ankylosing spondylitis

Published 2020

CADTH

“...The CADTH Canadian Drug Expert Committee (CDEC) recommends that ixekizumab be reimbursed...”

Read Now

125

CADTH Canadian Drug Expert Committee recommendation: Dupilumab (Dupixent -- Sanofi-Aventis Canada Inc.) : indication: atopic dermatitis

Published 2020

CADTH

Read Now

126

CADTH Canadian Drug Expert Committee final recommendation: Tesamorelin (Egrifta -- Theratechnologies Inc.) indication : HIV-associated lipohypertherapy

Published 2016

Canadian Agency for Drugs and Technologies in Health

Read Now

127

Vitamin D for the treatment or prevention of multiple sclerosis : a review of the clinical effectiveness

Published 2016

Canadian Agency for Drugs and Technologies in Health

Read Now

128

CADTH Canadian Drug Expert Committee final recommendation: Omalizumab -- resubmission (Xolair -- Novartis Pharmaceuticals Canada Inc.) : indication: asthma

Published 2016

Canadian Agency for Drugs and Technologies in Health

“...Canadian Agency for Drugs and Technologies in Health Canadian Drug Expert Committee final...”

Read Now

129

Concurrent probiotic and antibiotic use for in-patients : a review of the clinical and cost-effectiveness

Published 2015

CADTH Rapid Response Service

Read Now

130

Posaconazole for the treatment or prophylaxis of aspergillosis or candidiasis : a review of clinical effectiveness and guidelines

Published 2016

Canadian Agency for Drugs and Technologies in Health

Read Now

131

Over-the-counter nasal products for sinus congestion : a review of the clinical effectiveness

Published 2016

Canadian Agency for Drugs and Technologies in Health

Read Now

132

Bronchial thermoplasty for severe asthma : a review of the clinical and cost-effectiveness, and guidelines

Published 2015

Canadian Agency for Drugs and Technologies in Health

“... medical devices. This report is an update to a previous Canadian Agency for Drugs and Technologies...”

Read Now

133

Delivery of electroconvulsive therapy in non-hospital settings : a review of the safety and guidelines

Published 2014

Canadian Agency for Drugs and Technologies in Health

“... this therapy have been documented and the procedure is considered to be safe and efficacious. A recent Canadian...”

Read Now

134

Radiation emissions from computed tomography : a review of the risk of cancer and guidelines

Published 2014

Canadian Agency for Drugs and Technologies in Health

“.... Furthermore, frequent radiation exposure leads to high cumulative doses of radiation. The Canadian Nuclear...”

Read Now

135

HbA1c testing frequency : review of the clinical evidence and guidelines

Published 2014

Canadian Agency for Drugs and Technologies in Health

Read Now

136

Physical therapy treatments for chronic non-cancer pain : a review of guidelines

Published 2016

Canadian Agency for Drugs and Technologies in Health

Read Now

137

Delivery of electroconvulsive therapy in non-hospital settings : a review of the safety and guidelines

Published 2014

Canadian Agency for Drugs and Technologies in Health

“... this therapy have been documented and the procedure is considered to be safe and efficacious. A recent Canadian...”

Read Now

138

CADTH Canadian Drug Expert Committee recommendation: Tocilizumab (Actemra - Hoffmann-La Roche Limited) : indication : giant cell arteritis

Published 2018

CADTH

“...The CADTH Canadian Drug Expert Committee (CDEC) recommends that tocilizumab be reimbursed...”

Read Now

139

CADTH Canadian Drug Expert Committee recommendation: Obeticholic acid (Ocaliva--Intercept Pharmaceuticals Canada) : indication : primary biliary cholangitis

Published 2017

Canadian Agency for Drugs and Technologies in Health

Read Now

140

CADTH Canadian Drug Expert Committee recommendation: Levodopa/carbidopa intestinal gel (Duodopa -- Abbvie Corporation) : indication : Parkinson's disease

Published 2018

Canadian Agency for Drugs and Technologies in Health

“...The CADTH Canadian Drug Expert Committee recommends that levodopa/carbidopa intestinal gel (LCIG...”

Narrow Search